MPManasa Kumar Panda

Manasa Kumar Panda

*This is an algorithmically generated author record based on publicly available information.

Manasa Kumar Panda has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Predicting Biomarkers and Therapeutic Targets in Cancer

    by Rina Ningthoujam, Naorem BidyaLeima Chanu, Vivek Anumala, Punuri Jayasekhar Babu, Srimay Pradhan, Manasa Kumar Panda, Punabati Heisnam, Yengkhom Disco Singh


  • Open Access

    Insight from nanomaterials and nanotechnology towards COVID-19

    by Yengkhom Disco Singh, Rina Ningthoujam, Manasa Kumar Panda, Barsarani Jena, Punuri Jayasekhar Babu, Avanindra Kumar Mishra

    The pandemic disease coronavirus disease 2019 (covid-19) becomes one of the most dreaded disease in the history of mankind in the entire world. The covid-19 outbreak started from Wuhan city of China and then rapidly transmitted throughout the world causing mass destruction and seldom. This sporadical disease has taken many lives due to sudden outbreak and no particular vaccines were available at the early waves. All the vaccines developed are mostly targeted to spike protein of the virus and there is encapsulation of mRNA and nanoparticles. Nanotechnology intervention in the fighting against the covid-19 is one way to tackle the disease from different angle including nano coating mask, nano diagnostic kits, nano sanitizer, and nano medicine. This article highlights the intervention of nanotechnology and its possible treatment against the covid-19. It is high time to come together all the units of material science and biological science to fight against the dreaded covid-19. As an alternative strategy, a multidisciplinary research effort, consisting of classical epidemiology and clinical methodologies, drugs and nanotechnology, engineering science and biological apprehension, can be adopted for developing improved drugs exhibiting antivirals activities. Nanotechnology can be explored to detect, treat, and prevent the covid-19 disease.


  • Bioactive Molecules from the Alpinia Genus: A Comprehensive Review

    by Santwona Dash, Manasa Kumar Panda, Mayanglambam Chandrakumar Singh, Bimal Prasad Jit, Yengkhom Disco Singh, Jayanta Kumar Patra

    Background: Floral has diversity and unique nature due to the complex structure and component. Alpinia is an important genus of the Zingiberaceae family having complex taxonomical diversity. The presence of many unique bioactive molecules makes this genus, a pharmaceutically important genus. They provide a wide range of medicinal properties, including traditional remedies to modern therapeutic applications. Methods: Extracts of Alpinia mostly contain bioactive molecules and secondary metabolites such as polyphenolics, tannins, flavonoids and other therapeutically important compounds. These bioactive molecules are biologically active, treating against inflammation, cancer, arterial hypertension, and other deadly diseases. Results: These bioactive molecules can act as natural enzyme inhibitors for some of the deadly diseases and can block the pathway for metabolic activities. In addition, these genera have played a major role in multidisciplinary studies of phytochemistry, ethnobotany, and pharmacological aspects in day-to-day life. Conclusion: Therefore, this review highlights the fewer known facts of the genus Alpinia in terms of bioactive molecules and its significant therapeutic applications to help in combating major diseases of humans.